J. Korvick

发表

Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management.

V L Yu, V. Yu, M. Mulligan, 1993, The American journal of medicine.

Proton Pump Inhibitor Use in Infants: FDA Reviewer Experience

D. Griebel, Amy Taylor, J. Korvick, 2012, Journal of pediatric gastroenterology and nutrition.

Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy

D. Gerding, M. Wagener, C. Bryan, 1992, Antimicrobial Agents and Chemotherapy.

Mycobacterium avium-complex infection: progress in research and treatment.

C. Benson, J. Korvick, 1996 .

A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137).

D. Katzenstein, T. Merigan, P. Haslett, 1996, The Journal of infectious diseases.

Clarithromycin Therapy for Bacteremic Mycobacterium avium Complex Disease

C. Benson, L. Heifets, Ted M Smith, 1994, Annals of Internal Medicine.

A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.

J. Hodges, W. El-Sadr, C. Gibert, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Prospective Randomized Trial of Four Three-Drug Regimens in the Treatment of Disseminated Mycobacterium avium Complex Disease in AIDS Patients: Excess Mortality Associated with High-Dose Clarithromycin

David L. Cohn, James S. Hodges, David Munroe, 1999 .

Simpliying large trials: An example from the community programs for clinical research on aids

F. Gordin, J. Matts, J. Korvick, 1992 .

Organization, goals, and logistical challenges of the community programs for clinical research on aids

J. Neaton, D. Abrams, J. Korvick, 1992 .

Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: The cytomegalovirus retreatment trial

J. Phair, A. Wu, A. Friedman, 1996 .

High-dose pentoxifylline in patients with AIDS: inhibition of tumor necrosis factor production. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

M. Lederman, C. Flexner, B. Dezube, 1995, The Journal of infectious diseases.

Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group.

A. Pardee, B. Dezube, W. J. Novick, 1993, Journal of acquired immune deficiency syndromes.

Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration Adverse Event Reporting System.

J. Korvick, P. Honig, S. Singer, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDS.

D. DeMets, T. Fleming, J. Neaton, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Antimicrobial agent therapy for Pseudomonas aeruginosa

V. Yu, J. Korvick, 1991, Antimicrobial Agents and Chemotherapy.

Legionnaires' disease: an emerging surgical problem.

V. Yu, J. Korvick, Victor L. Yu, 1987, The Annals of thoracic surgery.

CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review.

D S Stein, S. Vermund, D. Stein, 1992, The Journal of infectious diseases.

Randomized Phase I Trial of Two Different Combination Foscarnet and Ganciclovir Chronic Maintenance Therapy Regimens for AIDS Patients with Cytomegalovirus Retinitis: AIDS Clinical Trials Group Protocol 151

John W Walker, M. Jacobson, B. Polsky, 1995 .

Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151.

M. Jacobson, B. Polsky, T. Hooton, 1994, The Journal of infectious diseases.

ndomized Study of Didanosine Monotherapy and Combination Therapy With Zidovudine in Hemophilic and Nonhemophilic Subjects With Asymptomatic Human Immunodeficiency Virus-l Infection

T. Merigan, U. Dafni, V. DeGruttola, 2002 .

Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients.

V. Yu, R. Muder, J. Korvick, 1989, The American journal of medicine.

Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem.

V. Yu, T. Starzl, J. Marsh, 1991, Surgery.

Cryptococcal tonsillitis in a patient with chronic lymphocytic leukemia: An unusual manifestation of cryptococcal disease

V. Yu, J. Korvick, 1987, American journal of hematology.

Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group.

D. Kuritzkes, C. Farthing, R. Steigbigel, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

T. Louis, N. Kimmel, W. El-Sadr, 1994, JAMA.

Women's Participation in AIDS Clinical Trials Group (ACTG) Trials in the USA: Enough or Still Too Few?

C. Spino, A. Bardeguez, P. Stratton, 1996 .

Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.

Paul E. Méndez, R. Haubrich, J. Phair, 1995, Archives of internal medicine.

A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

J. Neaton, N. Markowitz, R. Luskin-Hawk, 1994, The New England journal of medicine.

Clarithromycin Therapy for Bacteremic Mycobacterium avium Complex Disease

R. Chaisson, C. Benson, L. Heifets, 1994, Annals of Internal Medicine.

Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA): A Randomized Clinical Trial.

D. Strauss, R. Zusterzeel, Vikram Patel, 2021, JAMA.

Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitors.

P. Kluetz, J. Korvick, Paul Kluetz, 2012, The oncologist.

Two-stage tuberculin skin testing in individuals with human immunodeficiency virus infection

C. Salveson, K. Muth, F. Gordin, 1995 .

Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol

M. Lederman, W. Powderly, R. Reichman, 2000, The Journal of infectious diseases.

Response of CD4 lymphocytes and clinical consequences of treatment using ddI or ddC in patients with advanced HIV infection.

B P Carlin, B. Carlin, D. Abrams, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

A pink-pigmented, oxidative, nonmotile bacterium as a cause of opportunistic infections.

V. Yu, J. Rihs, J. Korvick, 1989, Archives of internal medicine.

Hospital pharmacists and infectious diseases specialists

G. Eliopoulos, D. Sexton, F. Tenover, 1997 .

Multiple-dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients

M. Chandler, R. Muder, J. Korvick, 1990, Antimicrobial Agents and Chemotherapy.

Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients.

V. Yu, R. Muder, J. Korvick, 1989, The American journal of medicine.

Addition of rifampin to combination antibiotic therapy for Pseudomonas aeruginosa bacteremia: prospective trial using the Zelen protocol

J. Korvick, J E Peacock, R R Muder, 1992, Antimicrobial Agents and Chemotherapy.

Susceptibility of 100 blood isolates of Pseudomonas aeruginosa to 19 antipseudomonal antibiotics: old and new.

V. Yu, J. Korvick, M. Hilf, 1987, Diagnostic microbiology and infectious disease.